Search research articles
Contact Us
Filters
Showing results (141-150 of 279) with videos related to
Page
of 28
Sort By:
Brain : a Journal of Neurology
|
July 22, 2022
Preclinical Alzheimer's disease biomarkers accurately predict cognitive and neuropathological outcomes
Justin M Long, Dean W Coble, Chengjie Xiong, et al.
Brain : a Journal of Neurology
|
June 12, 2016
The relationship between cerebrospinal fluid markers of Alzheimer pathology and positron emission tomography tau imaging
Brian A Gordon, Karl Friedrichsen, Matthew Brier, et al.
Neurology
|
September 10, 2021
Predicting Symptom Onset in Sporadic Alzheimer Disease With Amyloid PET
Suzanne E Schindler, Yan Li, Virginia D Buckles, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
July 24, 2017
Amyloid β concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis
Vitaliy Ovod, Kara N Ramsey, Kwasi G Mawuenyega, et al.
Current Alzheimer Research
|
February 6, 2015
Decreased platelet APP isoform ratios in autosomal dominant Alzheimer's disease: baseline data from a DIAN cohort subset
Pratishtha Chatterjee, Veer B Gupta, Anne M Fagan, et al.
JAMA Neurology
|
February 27, 2018
Proximity to Parental Symptom Onset and Amyloid-β Burden in Sporadic Alzheimer Disease
Sylvia Villeneuve, Jacob W Vogel, Julie Gonneaud, et al.
Neurology
|
March 8, 2019
ATN profiles among cognitively normal individuals and longitudinal cognitive outcomes
Anja Soldan, Corinne Pettigrew, Anne M Fagan, et al.
Brain : a Journal of Neurology
|
October 11, 2018
Incident cognitive impairment: longitudinal changes in molecular, structural and cognitive biomarkers
Catherine M Roe, Beau M Ances, Denise Head, et al.
Neurology
|
May 1, 2021
Temporal Correlation of CSF and Neuroimaging in the Amyloid-Tau-Neurodegeneration Model of Alzheimer Disease
Anna H Boerwinkle, Julie K Wisch, Charles D Chen, et al.
Brain : a Journal of Neurology
|
December 21, 2022
Proteomic clusters underlie heterogeneity in preclinical Alzheimer's disease progression
Julie K Wisch, Omar H Butt, Brian A Gordon, et al.
Page
of 28
Search research articles
Search
Showing results (141-150 of 279) with videos related to
Sort By:
Page
of 28
Brain : a Journal of Neurology
|
July 22, 2022
Preclinical Alzheimer's disease biomarkers accurately predict cognitive and neuropathological outcomes
Justin M Long, Dean W Coble, Chengjie Xiong, et al.
Brain : a Journal of Neurology
|
June 12, 2016
The relationship between cerebrospinal fluid markers of Alzheimer pathology and positron emission tomography tau imaging
Brian A Gordon, Karl Friedrichsen, Matthew Brier, et al.
Neurology
|
September 10, 2021
Predicting Symptom Onset in Sporadic Alzheimer Disease With Amyloid PET
Suzanne E Schindler, Yan Li, Virginia D Buckles, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
July 24, 2017
Amyloid β concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis
Vitaliy Ovod, Kara N Ramsey, Kwasi G Mawuenyega, et al.
Current Alzheimer Research
|
February 6, 2015
Decreased platelet APP isoform ratios in autosomal dominant Alzheimer's disease: baseline data from a DIAN cohort subset
Pratishtha Chatterjee, Veer B Gupta, Anne M Fagan, et al.
JAMA Neurology
|
February 27, 2018
Proximity to Parental Symptom Onset and Amyloid-β Burden in Sporadic Alzheimer Disease
Sylvia Villeneuve, Jacob W Vogel, Julie Gonneaud, et al.
Neurology
|
March 8, 2019
ATN profiles among cognitively normal individuals and longitudinal cognitive outcomes
Anja Soldan, Corinne Pettigrew, Anne M Fagan, et al.
Brain : a Journal of Neurology
|
October 11, 2018
Incident cognitive impairment: longitudinal changes in molecular, structural and cognitive biomarkers
Catherine M Roe, Beau M Ances, Denise Head, et al.
Neurology
|
May 1, 2021
Temporal Correlation of CSF and Neuroimaging in the Amyloid-Tau-Neurodegeneration Model of Alzheimer Disease
Anna H Boerwinkle, Julie K Wisch, Charles D Chen, et al.
Brain : a Journal of Neurology
|
December 21, 2022
Proteomic clusters underlie heterogeneity in preclinical Alzheimer's disease progression
Julie K Wisch, Omar H Butt, Brian A Gordon, et al.
Page
of 28